Losing 10 pounds, 20 pounds, 30 pounds is now as simple as taking a weekly shot or a daily pill
While these medications primarily reduce fat body mass (FBM), loss of lean body mass (LBM) can also occur, raising concerns about muscle loss in susceptible populations, such as frail individuals and older adults
Retatrutide is an investigational triple agonist still in active Phase 3 obesity development under Eli Lilly's J1I-MC-GZBJ master protocol, with no MHRA or EMA marketing authorisation as of 2026 [6][7]
Until now, TennCare has covered medications like Wegovy and similar drugs when prescribed for conditions such as diabetes or heart disease
We are working on the hybrid synthesis, where we make some [peptide] pieces with SPPS and then we will couple [them] together with an enzyme. So far they have done this for liraglutide using a unique ligation point the site where the enzyme couples two natural amino acids